US officials head to Berlin for drug pricing talks
Talks come as Germany scrambles to avoid U.S. tariffs over the way it prices new drugs.
Read original reporting ↗← Story archive
Business
US officials head to Berlin for drug pricing talks
Talks come as Germany scrambles to avoid U.S. tariffs over the way it prices new drugs.
Follow the evidence
Read the original report, then compare company disclosures and the relevant official data. A headline alone does not establish an effect on markets.
No additional matched coverage has been archived for this story yet.
This page preserves an attributed headline and brief excerpt. The publisher maintains the original report and any subsequent corrections. Report a classification or link issue →